An interventional study of Premixed Human Isophane Insulin Suspension + Human Insulin Injection and Premixed Insulin in Diabetes Mellitus, Type 2, sponsored by Aristotle University Of Thessaloniki. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-27.
Sponsored by Aristotle University Of Thessaloniki · Not applicable, Interventional, and Treatment
Comparison of Two Biphasic Insulin Regimens in Well-controlled Patients With the Use of Continuous Glucose Monitoring and New Glycemic Control Indices
A cross-over study of 36 well controlled people with type 2 Diabetes Mellitus who underwent 7-day Continuous Glucose Monitoring with Premixed Human Insulin 30/70 and subsequently with Biphasic Aspart 30.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's enrollment of 36 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Aristotle University Of Thessaloniki is the lead sponsor of 274 studies on the registry; 56 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Premixed Human Insulin
Drug: Premixed Human Isophane Insulin Suspension + Human Insulin Injection · Drug: Premixed Insulin
Premixed Insulin Analog
Drug: Premixed Human Isophane Insulin Suspension + Human Insulin Injection · Drug: Premixed Insulin
premixed human insulin
Also known as: premixed human insulin
Premixed Insulin Analog Biphasic Aspart 30
Also known as: Biphasic Aspart 30
Change in average blood glucose
average blood glucose (mg/dl) from continuous glucose monitoring
Time frame: 7 days
Glycated Albumin
levels of glycated albumin (%) in serum
Time frame: 7 days
Fructosamine
levels of fructosamine (μmol/L) in serum
Time frame: 7 days
Daily Insulin requirements
change in total daily dose of insulin (u)
Time frame: 7 days
nocturnal average blood glucose
change in nocturnal average blood glucose
Time frame: 7 days
Time in range
change in time in range (% and minutes) from continuous glucose monitoring
Time frame: 7 days
time above 180
change in time above 180 (% and minutes) from continuous glucose monitoring
Time frame: 7 days
time below 70
change in time below 70 (% and minutes) from continuous glucose monitoring
Time frame: 7 days
No study locations are listed for this record.
Plan to share: No — Upon request
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aristotle University Of Thessaloniki